In patients with metastatic lung SCC who are on pembrolizumab maintenance after starting pembrolizumab/carboplatin/nab-paclitaxel, what is your treatment strategy if they progress while on pembrolizumab alone?   

Would you continue pembrolizumab with a re-challenge with carboplatin/taxane or move to second line therapy?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Pittsburgh
I agree with Dr. @Stephen V. Liu. If the response...
Medical Oncologist at Northwest Georgia Oncology Centers
We've also continued IO and added a dash of radiat...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice